The European market for heart valve devices will grow through 2027, fueled by an expanding aging population and rising adoption THV devices, reflecting the accumulation of favorable clinical data for the use of these devices for patient populations usually treated with surgical devices.
This Medtech 360 Report provides high-level market metrics for heart valve devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
- Heart Valve Devices - Market Insights - Europe (Supplemental)
Author(s): Drew Wallace
Drew C. Wallace is an analyst on the Cardiovascular Medtech Insights team, specializing in heart valve and cardiac rhythm management device markets. Drew holds a Master's degree in Developmental Biology from the University of Western Ontario. Prior to his current position, Drew worked at the Princess Margaret Cancer Centre on the immunotherapy clinical trial program.